J0179 Injection, brolucizumab-dbll, 1 milligrams
J-Codes
Also known as: brolucizumab, Beovu
Brolucizumab-dbll injection 1 milligram, a single-chain VEGF inhibitor for retinal diseases.
Clinical Context
Intravitreal single-chain anti-Vascular endothelial growth factor antibody for age-related macular degeneration, diabetic macular edema. Designed with longer durability allowing less frequent dosing.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.